Sign in →

Order Code HCVG Hepatitis C Virus Genotype, Serum

Additional Codes

Mayo Test ID:  HCVG

Reporting Name

HCV Genotype, S

Useful For

Determining hepatitis C virus (HCV) genotype (1 to 5) to guide antiviral therapy in patients with chronic hepatitis C

 

Differentiating between HCV subtypes 1a and 1b

 

This assay should not be used as a screening test for HCV infection. It should be performed only on specimens obtained from patients confirmed to have HCV RNA levels in serum of 500 IU/mL or higher.

Specimen Type

Serum SST


Shipping Instructions


Ship specimen frozen on dry ice only. If shipment will be delayed for more than 3 days, freeze serum at -20° C or colder (up to 42 days) until shipment on dry ice.



Specimen Required


Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube: Serum gel (red-top tubes are not acceptable)

Submission Container/Tube: Plastic vial

Specimen Volume: 5 mL

Collection Instructions:

Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.

Additional Information:

1. This test requires a minimum hepatitis C virus viral load of 500 IU/mL within the 30 days preceding collection.

2. Serum specimens previously submitted to other laboratories for non-microbiology tests are not acceptable for add-on test requests due to possible sample-to-sample carryover from automation used for those tests.


Specimen Minimum Volume

1.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum SST Frozen (preferred) 42 days ALIQUOT TUBE
  Refrigerated  72 hours ALIQUOT TUBE

Reject Due To

Gross hemolysis OK
Gross lipemia OK

Reference Values

Undetected

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Day(s) Performed

Monday through Friday

Method Name

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) followed by Hybridization with Sequence-Specific, Fluorescent-Labeled Oligonucleotide Probes

CPT Code Information

87902

Testing Algorithm

Specimens either generating indeterminate genotype results, results with multiple or mixed hepatitis C virus genotypes (eg, 1, 5; 1, 2; or 1, 5), or those containing genotype 1 with no subtype will be automatically evaluated with by genotype resolution at an additional charge.

 

The following algorithms are available:

-Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Antigen (DAA) Combination

-Hepatitis C: Testing Algorithm for Screening and Diagnosis

Method Description

Sample Preparation:

The Abbott mSample Preparation System kit is used with the Abbott m2000sp, an automated sample preparation system using the magnetic microparticle processes to extract and purify viral nucleic acids from human serum specimens. An internal control is incorporated in the nucleic acid extraction and purification procedure for processing the assay controls and clinical specimens. After capture of nucleic acids onto magnetic microparticles, the microparticles are washed to remove unbound sample components. Then, the bound nucleic acids are eluted from the microparticles, and the eluates are transferred to a 96-well microtiter plate containing polymerase chain reaction (PCR) mastermix reagents for amplification and detection.

 

Amplification, Detection, and Genotyping:

The Abbott RealTime HCV Genotype II assay is used to amplify the 5' noncoding (5' NC), nonstructural 5b (NS5b), and core regions of the hepatitis C virus (HCV) genome, with several PCR primer sets that are optimized to amplify all HCV isolates. An internal control primer set is included to amplify a portion of the hydroxypyruvate reductase gene of the pumpkin plant, Cucurbita pepo. The assays positive control is an armored RNA particle diluted in negative human plasma.

 

During the amplification reaction, complementary DNA (cDNA) sequences are generated from the target RNA sequences by the reverse transcriptase activity of the thermostable rTth DNA polymerase. First, the HCV and internal control reverse primers anneal to their respective target sequences and are extended during a prolonged incubation period. After a denaturation step, in which the temperature of the reaction is raised above the melting point of the double-stranded cDNA:RNA product, a second primer anneals to the cDNA strand and is extended by the DNA polymerase activity of the rTth enzyme to create a double-stranded DNA product. During each round of thermal cycling, amplification products dissociate to single strands at a high temperature, allowing primer annealing and extension as the temperature is lowered. Exponential amplification of the product is achieved through repeated cycling between high and low temperatures, resulting in a billion-fold or greater amplification of target sequences. Fluorescent probes specific for HCV genotypes 1 to 5 and subtypes 1a and 1b anneal to the amplified sequence products in 4 separate reaction wells for each specimen.(Package insert: RealTime HCV Genotype II. Abbott Molecular Inc; R1, 06/2013)

Reflex Tests

Test ID Reporting Name Available Separately Always Performed
HCVGR HCV Genotype Resolution, S No No

Forms

If not ordering electronically, complete, print, and send 1 of the following:

-Gastroenterology and Hepatology Test Request (T728)

-Microbiology Test Request (T244)